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Abstract: Pain is a frequent issue in children with profound intellectual and multiple disabilities
(PIMD). Its identification and treatment can prove highly challenging for primary care physicians,
mainly because of the children’s limited communication abilities. We used an online survey to
explore paediatricians’ views regarding the experience and management of pain in children with
PIMD and invited 480 professionals working in the canton of Vaud, Switzerland, to take part. We
received 121 responses (participation rate 25.5%). A large majority of respondents provided care
to children with PIMD. All paediatricians considered that these children feel pain at least as much
as typically developing children. However, paediatricians had mixed views on their tolerance
to pain. More than 90% held the view that their pain is under-assessed and undertreated. The
principal barriers they reported to appropriate management were communication limitations with
the child, difficulties in pain assessment, lack of knowledge about children with disabilities and lack
of experience. Paediatricians have complex opinions regarding how children with PIMD experience
pain and how to manage this problem. Professional education and training on the specificities of
children with PIMD, including how to address their pain, seem necessary to foster paediatricians’
ability and confidence in approaching this complex issue.
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1. Introduction
The prevalence of children with profound intellectual and multiple disabilities (PIMD)
is estimated to be between 0.4 and 1.3h [1,2]. PIMD is defined by the association of (1) a
severe to profound intellectual disability with (2) a significant motor impairment leading
to (3) complex health care needs and high dependency in daily activities [2]. Furthermore,
individuals with PIMD have extremely delayed intellectual and social functioning, with
little or no apparent understanding of verbal language and little or no symbolic interaction
with objects. Therefore, standard pain self-assessment is usually compromised, and the
challenge of communicating with these children can lead to major difficulties in pain
evaluation by their healthcare providers, contributing to inefficient pain management [3,4].
The International Association for the Study of Pain recently revised its definition of
pain as “an unpleasant sensory and emotional experience associated with, or resembling
that associated with, actual or potential tissue damage” [5]. This definition accounts for
the subjective nature of pain and does not equate pain with self-reporting or the ability
to self-report. Therefore, it also applies to children with neurological disabilities who are
unable to express their pain in words. The definition acknowledges that the pain experience
integrates both sensory and emotional components, with the brain supporting a complex
interaction between nociception, the feeling of unpleasantness and emotional states such
as distress, anxiety or fear [6]. Pain can impact all areas of life, including sleep, mood and
interactions with others, but also physical and cognitive abilities [7]. This is even more
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important in children with PIMD, for whom pain can significantly worsen the major func-
tional limitations associated with their neurological condition. Considering that children
with PIMD are at a higher risk of experiencing pain due to their medical complexity [8],
efficient pain identification and management are essential in this population. Common
sources of nociceptive pain in PIMD are skeletal (hip subluxation, scoliosis, osteopenia and
pathological fractures), related to neuromotor disorders (spasticity, dystonia, dyskinesia
and immobility), digestive (gastroesophageal reflux, constipation and dysmotility) and
iatrogenic (investigations, surgery and physiotherapy) [9,10]. Problems with mobility and
posture may lead to pressure sores or distortion of internal organs. For certain children
with PIMD, even habitual daily care activities, such as dressing, may be associated with
significant pain [8]. In addition, central nervous system processes contribute to amplify
their pain experience, notably central sensitization, neuropathic pain and autonomic dys-
function [10]. In one cohort study, half of the children with severe cognitive impairment
had pain at least weekly, with an average duration of nine hours per week [11]. Half of
those in another registry-based study of children with severe cerebral palsy regularly expe-
rienced pain, primarily musculoskeletal pain [12]. Even young children have significant
pain. In a cross-sectional study of children with cerebral palsy aged 5 to 10 years, pain was
present in 52% of the children at all severity levels, restricting their daily lives, especially
sleep, schoolwork and being with friends [13].
Long-held beliefs among parents and physicians of children with PIMD suggest
that individuals with intellectual disabilities have an impaired perception of pain. Sev-
eral studies have refuted this suggestion [14]. However, these beliefs seem to persist in
clinical practice and can be part of why children with PIMD may be at a higher risk of
poor pain management [3]. Valkenburg et al. [15] surveyed Dutch anaesthesiologists,
specifically focusing on their management of perioperative pain and their knowledge of
pain assessments for non-communicating children, and explored their beliefs about these
children’s subjective experience of pain. A majority thought that disabled children were
not more sensitive to pain and did not require more analgesia than typically developing
children. Very few were aware of pain scales specifically developed for children with
limited communication abilities.
There are few studies in children with PIMD regarding pain assessment (mostly re-
garding clinical assessment tools) and pain management, and these have rarely explored
the opinions and attitudes of healthcare professionals [4,15,16]. None have specifically
included primary care physicians who are at the forefront of pain identification and man-
agement within the healthcare system. Consequently, our study aimed to (1) explore
paediatricians’ views regarding the experience and management of pain in children with
PIMD and (2) investigate whether paediatricians’ demographic and professional character-
istics were associated with their views of pain in children with PIMD.
2. Materials and Methods
2.1. Design
We conducted a cross-sectional descriptive study using an online survey.
2.2. Population
We invited all professionally active physicians working in general paediatrics and
paediatric subspecialties in the canton of Vaud, Switzerland (population 800,162 inhabi-
tants), to take part. Undergraduate medical students were excluded. We invited a total
of 480 professionals, 177 paediatricians working in community practice and 303 paediatri-
cians working in hospitals. Nineteen professionals worked in both settings.
2.3. Survey Development and Content
We used Valkenburg et al.’s questionnaire to develop our survey [15]. We completed
the questionnaire with questions extracted from the thematic analysis of the transcribed
outputs of five semi-structured interviews with key stakeholders. These stakeholders
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included a physiotherapist, a nurse working in a special needs school, a nurse who special-
ized in palliative care, a hospital paediatrician and a representative of a parents’ association.
These interviews focused, from a multi-professional perspective, on the challenges and
difficulties in pain care for children with PIMD and on the resources at the disposal of
each interviewee. The five concurring themes that emerged from the analysis were (1) the
experience of pain in children with PIMD, (2) assessing their pain, (3) managing their pain,
(4) barriers to providing them with appropriate medical care and (5) barriers to treating
their pain with medication.
The survey explored (1) eight demographic and professional characteristics of the
participants (gender, age, place of employment, country of origin, country of study, the
field of current paediatric activity, years of experience in paediatrics, years of experience in
current activity), (2) professional exposure to children with PIMD, (3) physicians’ opinions
on the pain experience of children with PIMD and (4) physicians’ pain assessment and
management of children with PIMD. Each item was formulated as a statement, with
agreement versus disagreement toward the statement graded on a four- to five-point Likert
scale (with an additional neutral response for knowledge-based questions).
Before starting data collection, the questionnaire was submitted to two hospital-based
paediatricians working in the field of paediatric disability, who independently validated
its content.
2.4. Data Collection
The survey was anonymous, in French and made available online via Google forms.
Paediatricians working in community practices were contacted through the mailing list
of their professional association (Groupement des Pédiatres Vaudois) and paediatricians
working in hospitals through the heads of paediatric departments of the University Hospital
(CHUV, Lausanne) and five regional hospitals (Aigle, Vevey, Morges, Nyon, Yverdon).
Participants received an email invitation to take part in the survey. Response to the
survey implied consent. Data collection began in May 2019. We sent two reminders with a
delay of three weeks in between, and the survey was closed one month after the last reply.
Because the study included healthcare professionals and was strictly anonymous,
formal agreement by the regional ethics commission was waived, according to the Swiss
Federal Act on Research Involving Human Beings, art. 2.2 al. c [17].
2.5. Data Analysis
Data were analysed descriptively by counts and proportions. For data analysis, given
our sample size, responses were grouped into two to three categories (e.g., disagree, agree
and an additional neutral response for the knowledge-based questions). For demographic
and professional characteristics, age, experience and time in current activity were cate-
gorised in 5- to 10-year ranges. Countries of origin and study were classified between
Switzerland, Europe or other. Current activity was classified between general paedia-
tricians, neuropaediatricians (including neurologists, neurorehabilitation specialists and
developmental paediatricians) and other paediatric specialists (for a complete overview of
specialities, see question 5 in Supplementary Materials Table S1). Based on the notion of
consensus in Delphi processes [18], we then classified the responses as consensual, when
≥80% of participants provided the same response, and non-consensual, when <80% of
participants provided the same response. For non-consensual responses, we performed
association analyses between demographic and professional characteristics and the re-
sponses of the participants using cross-tabulation and chi-square tests. After applying
the Bonferroni correction to decrease the risk of false positive significance and fortuitous
findings due to multiple comparisons, p ≤ 0.0063 was considered significant (p-value of
0.05 corrected by the eight demographic and professional characteristics). We used SPSS
Statistics v.25 (IBM, Armonk, NY, USA) to perform the analyses.
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3. Results
3.1. Survey Population
The participation rate was 25.5% (121 responses out of 480 invites). There were
no missing data in the responses. There was no significant difference in response rates
(χ2(1480) = 1.01, p = 0.31) between paediatricians working in hospitals (26.7%) and those
working in the community (22.6%). The demographic and professional characteristics
of the respondents are reported in Table 1. A large majority of the respondents (96.8%)
reported taking care of children with PIMD in their practice, more than half regularly, that
is, at least once per month (51.2%).
Table 1. Personal characteristics of survey respondents.






25–34 35–44 45–54 >55
39 (32.2%) 36 (29.8%) 31 (25.9%) 15 (12.4%)
Country of origin
Switzerland Europe Other
89 (73.5%) 29 (23.9%) 5 (4.1%)
Country of study
Switzerland Europe Other
96 (79.3%) 22 (18.2%) 4 (3.3%)
Current activity
General paediatricians Neuropaediatricians Other paediatric specialists
87 (71.9%) 12 (9.9%) 22 (18.2%)
Experience in
paediatrics (years)
0–5 6–10 11–20 >20
33 (27.3%) 17 (14%) 44 (36.4%) 27 (22.3%)
Current activity
(years)
0–5 6–10 11–20 >20
52 (43%) 30 (24.8%) 28 (23.1%) 11 (9.1%)
Place of work
Hospital Community
81 (66.9%) 40 (33.1%)
3.2. Survey Responses
3.2.1. The Experience of Pain in Children with PIMD
A majority of paediatricians considered that children with PIMD experienced pain
in the same way as typically developing children and 20% considered that the experience
of pain was higher for children with PIMD. Tolerance to pain was judged as higher in
children with PIMD by a quarter of respondents and lower by a fifth (Figure 1).
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Figure 1. Paediatricians’ (n = 121) views on the pain experience of children with profound intellectual and multiple
disabilities (PIMD) compared with typically developing (TD) children.
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If most participants (94.2%) responded that there was no correlation between the
severity of disability and sensitivity to pain, most (90.1%) agreed that the more severe the
disability, the higher the difficulty in distinguishing pain from other negative emotions. A
majority of paediatricians (78.5%) agreed that each pain experience included an emotional
response in children with PIMD, and a slim majority (52%) responded that the emotional
response to pain of children with PIMD differed from that of typically developing children.
3.2.2. Pain Assessment
A large majority of respondents (95%) agreed that the pain of children with PIMD
was under-evaluated. Around half (52.1%) answered that the use of pain scales was
more important than with typically developing children, and around the other half (46.3%)
answered that the use of pain scales was as important as with typically developing children.
Around half of the participants (49.6%) were familiar with the scales validated for
the assessment of pain in children with PIMD. The most known scales were the Face,
Legs, Activity, Cry, Consolability (FLACC) scale [19] (44.6%) and the Douleur Enfant San
Salvadour scale [20] (36.4%). These were also the most used (respectively, 34.7% and 24.8%).
More than half (51.2%) of the paediatricians did not use pain scales for these children.
3.2.3. Pain Management
The vast majority of respondents reported that pain was undertreated in children with
PIMD, and a minority reported that it was overtreated. More than half of the respondents
considered pain to be more difficult to relieve in children with PIMD.
Regarding analgesics, two-thirds responded that children with PIMD needed them
more frequently, and opinions were mixed about their effectiveness compared to typically
developing children.
Most of the participants disagreed with prescribing a round-the-clock analgesic treat-
ment, but a large majority responded that an on-demand treatment should be prescribed
for suspected pain without the need for additional medical guidance (Figure 2).
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Figure 2. Paediatricians’ (n = 121) views on pain management of children with PIMD.
3.2.4. Barriers to the Appropriate Medical Care of Children with PIMD
Paediatricians reported that the main barriers to appropriate clinical management
of children with PIMD were limited communication with the child (84.2%), difficulties
in pain assessment (82.6%), lack of personal experience (71.9%) and lack of knowledge
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about disabled children (71.9%). Less than half of the participants (47.1%) reported a lack
of knowledge about pain as a barrier to the adequate care of children with PIMD.
3.2.5. Barriers to Treating Pain with Medication in Children with PIMD
Two-thirds of respondents (68.5%) considered the possibility of masking the source of
pain with analgesics to be a potential barrier to treating pain with medication. Conversely,
a minority of respondents considered the risk of addiction to analgesics (17.4%), the fear
of adverse effects of opioids (28.1%), parental pressure (27.3%) and the fact that treatment
could hinder the investigation of potential sources of pain (33.1%) as significant barriers to
analgesic treatment. Respondents had mixed views about the fear of respiratory depression
with opioids, with less than half (46.2%) considering this as a barrier to treatment.
3.2.6. Association Analyses of Non-Consensual Responses
Non-consensual views were present within all five themes of the survey: for experi-
ence of pain, 3/6 of the questions had non-consensual responses; for assessment of pain,
2/3; for management of pain, 3/7; for barriers to providing appropriate medical care, 3/5;
and for barriers to treatment with analgesics, 6/7. Only certain professional characteristics
demonstrated significant associations with these non-consensual responses.
Neuropaediatricians were significantly more likely to agree that pain was over-treated
in children with PIMD (9/22 of neuropaediatricians agreed compared with 12/99 of other
paediatricians, χ2(1121) = 10.4, p = 0.001).
General paediatricians were more likely to agree that pain might be masked by
analgesic treatment than neuropaediatricians and other paediatric specialists (34/87 of
general paediatricians agreed compared with 3/31 of paediatric specialists, χ2(1121) = 10.5,
p = 0.001).
Paediatricians working outside hospitals were more likely to agree that the fear of
the adverse effects of opioids could be a barrier to adequate pain treatment in children
(18/40 of community paediatricians agreed compared with 17/81 of hospital paediatricians,
χ2(1121) = 7.5, p = 0.006).
4. Discussion
Our study suggests that paediatricians, a large majority of who provide care to children
with PIMD, have complex opinions regarding how these children experience pain and how
to manage this issue. These views were largely unrelated to the physicians’ demographic
and professional characteristics, with a few exceptions.
Despite longstanding beliefs about pain insensitivity or indifference in persons with
intellectual disabilities [21,22], none of the respondents believed that children with PIMD
experienced pain less than typically developing children. Our findings are in line with
those of Valkenburg et al. [15], who found that around 60% of anaesthetists considered
children with intellectual disabilities equally sensitive and 30% considered them more
sensitive to pain than typically developing children. Limited research in children with
neurodevelopmental disabilities has demonstrated that their pain thresholds are similar
to [23], if not lower than [24], those of children with typical development. This is possibly
related to alterations in somatosensory processing associated with cerebral impairment [25].
However, paediatricians had more mixed views on the way children with PIMD modulate
their experience and expression of pain, with a lack of consensus on how they tolerate
pain. Whether children with severe cognitive limitations can present adaptive coping to
pain is largely undetermined, with a lack of knowledge on the resilience factors, both
personal and environmental, that could influence the lived experience of pain in this
population [26]. Children with intellectual disabilities experience more pain and anxiety
during needle-related procedures than typically developing children [27]. Additionally,
recent research by near-infrared spectroscopy has shown that children with severe to
profound intellectual disabilities demonstrate cortical activation during venepuncture
that typically developing children do not [28]. This suggests that children with PIMD
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go through a different subjective experience of pain compared with their cognitively
unimpaired peers and that this different experience may be related to distress in children
who are unable to rationalise unfolding events related to painful procedures. Beyond the
biological and psychological determinants of pain, it is likely that social determinants, such
as the attitudes of parents or other caregivers, also modulate the experience and expression
of pain, as conceptualized in Craig’s social communication model of pain [29].
Paediatricians mostly acknowledged the emotional component of pain in children with
PIMD beyond pure nociception; however, half thought that it differed from the emotional
experience of children with typical development. Distinct neural systems support the pain
experience. The lateral pain system supports the sensory-discriminative dimension of pain
by identifying the characteristics of painful stimuli. The medial pain system underpins the
affective-motivational dimension of pain, which is most closely associated with emotion
and is the core of the unpleasantness generated by nociception. A third aspect, strongly
intertwined with both previous dimensions, is the cognitive dimension under higher
cortical control, which influences the appreciation and understanding of pain [6]. One can
reasonably hypothesise that abnormal cerebral function and severe cognitive impairment
in children with PIMD can alter the experience of pain, especially in its higher processing.
However, their communication difficulties limit our ability to verify this hypothesis.
Paediatricians largely held the view that pain was under-assessed and undertreated
in children with PIMD. This concurs with a previous study exploring the attitudes of
clinicians regarding pain and cognitive impairment in a large children’s hospital, where
99% of physicians encountered difficulties in pain assessment and 71% of all clinicians
reported that analgesics were under-prescribed for these children [4]. Although a large
majority of our sample estimated that the use of validated pain assessments was at least
as important for children with typical development, only half of the respondents knew
and used these pain scales in their clinical practice. Lack of familiarity and awareness of
available tools, organizational and time constraints and the absence of a clear consensus
as to which scales should be used in routine practice are all factors that can act as barriers
to the adequate implementation of pain scales in daily practice [14]. Moreover, there is
evidence that health professionals experience a lack of confidence in this type of care
despite the existence of valid tools [30]. Our proportion of users is a major improvement on
previous figures, with only 1 in 55 paediatric wards in North-Eastern Italian hospitals using
pain scales adapted to children with cognitive impairments in 2011 [31]. Similarly, only 4%
of child anaesthetists reported the use of a pain assessment tool validated for children with
severe neurological impairments in 2019 [15]. A few behavioural pain assessment tools
have been validated in this population. Most of them rely on documentation of baseline
childhood behaviour with regular caregivers to detect further changes of behaviour that
could prove indicative of pain and allow the inclusion of less typical pain behaviours, such
as increased muscle tone, self-injury or laughing [32].
Despite reporting a tendency to undertreat children with PIMD, a majority of respon-
dents believed they needed analgesics more frequently than typically developing children
do, and a large majority warranted on-demand analgesic treatment for this population.
However, very few advocated for round-the-clock treatment, and less than half of the
respondents believed that analgesics had the same effectiveness in children with PIMD as
in typically developing children. This contrasts with the opinions of anaesthetists, among
whom only a small minority believed that children with intellectual disabilities required
more analgesia [15]. However, these opinions specifically addressed peri-procedural pain.
Paediatricians considered analgesics to be less effective in children with PIMD, but favour-
ing on-demand administration may have contributed to this perception. The contrasting, if
not paradoxical, views of paediatricians, who generally considered children with PIMD
as undertreated but refrained from prescribing round-the-clock medication, reflects the
perceived complexity of providing analgesia to these children. Not only is this related
to the difficulty in identifying the presence, source and extent of pain but also because
several pain behaviours in children with PIMD are compounded by an imbalance between
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inhibitory and excitatory signals treated by the central nervous system within the context
of their impaired cerebral function. Certain children ultimately present opioid-resistant
pain behaviours, especially in the case of recurrent or chronic pain, and adapted pain
ladders (e.g., the “neuro-pain” ladder), including the early use of gabapentinoids, have
been suggested for this population [33]. Lack of familiarity with such guidelines, added
to the complexity of these children’s conditions, may further contribute to paediatricians’
difficulties in providing effective analgesia. Indeed, features such as muscle weakness,
co-morbidities, including malnutrition or respiratory insufficiency, and concomitant medi-
cation or even polypharmacy must all be considered when prescribing analgesic medication
for children with PIMD because these can significantly interfere with dosages and duration
of treatment and contribute to side effects [34].
More than 40% of neuropaediatricians, significantly more than the 12% of other
paediatricians, reported a tendency to overtreat pain in children with PIMD. This could
reflect the view among certain neurological specialists that a proportion of behaviours
attributed to pain that children with PIMD exhibit are inappropriately treated by opioid
prescription. First, they may consider that opioids are not the medication of choice as an
early line of treatment, especially for chronic pain in children with PIMD. Second, these
specialists have more experience with children with neurological disabilities and have a
stronger knowledge of the variety and complexity of behavioural issues and expressions
that accompany severe to profound intellectual disability. They may therefore be more
attuned to distinguishing expressions of pain from similar behaviours caused by other
stressors or by their cerebral impairment.
The major issues reported by paediatricians in providing appropriate medical care to
children with PIMD were their lack of knowledge about disability, their limited experience
with disabled children, and difficulties in communicating with non-verbal children and
in evaluating their pain. Weaknesses in the training of physicians about cognitive and
physical disabilities in children have been reported previously [35–37]. Up to three-quarters
estimated that they were not sufficiently trained to confidently care for these children, most
of their knowledge being acquired informally through on-the-job training and through
mentorship. If children with PIMD have strongly limited communication capabilities, with
a restricted, if not absent, ability to self-report pain, physicians should always explore
limited self-reporting as a possible means of collecting pain information [21]. Pain may
also prove difficult to distinguish from other conditions, such as distress, anger, sadness or
anxiety, even for familiar caregivers, with an overlap in expressed behaviours [38]. Less
than half of paediatricians reported a lack of knowledge about pain as a barrier to the
management of children with PIMD. Around 80% of our sample received their medical
education in Switzerland, where pain is one of the generic situations that all physicians are
expected to be able to manage on day one of their residency after graduating from medical
school [39].
The principal barriers to prescribing pain medication in children with PIMD reported
by paediatricians were the fear of masking the source of pain, followed by the risk of
respiratory depression linked to opioids and the concern that symptomatic medication
could slow or hinder the correct investigation of pain. The fear that effective pain treatment
will mask pain in children with limited communication abilities, especially from a new
source of pain, is common among prescribers [32]. However, a case series of children with
severe neurological impairments showed that while they were being treated efficiently
for recurrent pain behaviours, the onset of new pain behaviours allowed the diagnosis of
new sources of pain, such as urinary tract infections [40]. Likewise, there is no evidence
of a decrease in the etiological investigations of pain in children with disabilities who
receive appropriate pain medication. The concern of masking pain was significantly more
prevalent among general paediatricians, possibly because they intervene earlier and have a
more global view of the clinical workup of pain behaviours than speciality paediatricians
do. The fear of missing a diagnosis that could be detected if pain were not masked
by analgesics may be higher for first-line professionals who are in charge of the global
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healthcare of children with PIMD, especially since the expression of pain is a problem for
these children. This may contribute to the conservative attitude of paediatricians who, as
discussed above, seem to refrain from prescribing round-the-clock analgesia, favouring
on-demand treatment. Fear of respiratory depression linked to opioids is a common
concern among health professionals who care for children. Multiple studies have shown
that opioids are effective and safe in children when they are appropriately introduced and
titrated appropriately [41]. However, children with PIMD may prove more challenging
due to associated risk factors, such as poor airway control or hypoventilation [21]. This
concern was significantly higher among community-based paediatricians. They are far
less likely to prescribe opioids in their practice than hospital-based professionals, do not
have direct access to the multidisciplinary resources of a hospital, such as pain teams, and
are less familiar with the processes that allow for the secure prescription and follow-up of
opioid treatments.
Our study’s main limitation is that we cannot exclude a degree of responder bias
with a 25% participation rate. However, the age and gender structure of our sample was
representative of paediatricians, both within our recruitment area and at the national
level [42]. We were not able to control further for non-responders for whom we had
no personal or professional data. Our sample size and the size of certain subgroups of
participants may have limited our ability to detect certain associations between personal
characteristics and non-consensual responses. This study was based on self-reported
practice, and it is impossible to know how well our results reflect actual practice. Further
observational studies on clinical assessment and management practices in this population
are needed. Finally, we performed the study in a single region, and our results may not
reflect wider variations in paediatricians’ views on this subject at the international level.
5. Conclusions
Paediatricians’ views and beliefs about the pain of children with PIMD are equivocal
and complex. Caring for children with PIMD entails navigating uncertainty, and previous
qualitative research has shown that this erodes professional confidence due to perceived
deficits in both skill and knowledge sets [43]. A large part of our respondents acknowledged
their difficulties and limits in assessing and managing pain in this group of children but
had a genuine willingness to do well. Half of our sample showed some familiarity with
dedicated pain scales. Professional education and training on the specificities of children
with PIMD, including how to address their pain, seem necessary to foster their ability and
confidence in approaching this complex issue. Ideally, this training should be grounded in
evidence. This still demands strengthening given the relatively scarce research into pain in
this population, which is often excluded from pain studies because of functional limitations,
methodological issues surrounding pain ascertainment and measurement and the difficulty
in achieving appropriate sample sizes for exploratory and interventional studies. We
believe that by furthering both professional education and research into pain in children
with PIMD, the quality of their care and, ultimately, their quality of life will improve.
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